Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
We report results of the studies relating to the fabrication of nanostructured zirconia (ZrO2) based immunosensor for
cardiac troponin I biomarker (myocardial infarction) detection. One step, low temperature hydrothermal process
has been used for the synthesis of nanostructured ZrO2 (4.5 nm). These ZrO2 nanoparticles have been functionalized with
3-amino propyl triethoxy silane (APTES) and thereafter electrophoretically deposited (15 V, 3 minutes) on indium tin oxide
coated glass electrode (ITO). EDC/NHS chemistry has been used for covalent immobilization of anti-troponin-I (anti-cTnI)
onto APTES/ZrO2/ITO electrode. Structural, morphological and functional characterization of the synthesized nanoparticles
and the fabricated immunoelectrode have been carried out via X-ray diffraction (XRD), transmission electron microscopy
(TEM), atomic force microscopy (AFM), fourier transform infrared spectroscopy (FTIR) and cyclic voltammetry techniques.
The results of electrochemical response studies of BSA/anti-cTnI/APTES/ZrO2/ITO immunoelectrode reveal that this smart
platform can be used for the detection of troponin I biomarker with a wide linear detection range (0.01 to 100 ng mL-1), high
sensitivity (3.7Ã?Â?10-4 mA mL ng-1 cm-2), remarkable lower detection limit (0.036 ng mL-1) and stability of upto 30 days. The
obtained results have been validated through enzyme linked immunosorbent assay (ELISA).